Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plethico’s Natrol Acquisition Reflects Growing Indian Supplement Investment

This article was originally published in The Tan Sheet

Executive Summary

Plethico Pharmaceuticals' $80.8 million acquisition of Natrol could be a bellwether of Indian firms' interest in growing their presence in the U.S. supplement market
Advertisement

Related Content

$25 Million ‘Pure Fiction’ In Natrol Price Tag Made Real
$25 Million ‘Pure Fiction’ In Natrol Price Tag Made Real
Supplement Space Exits: Bankruptcy Traffic Could Accelerate
Supplement Space Exits: Bankruptcy Traffic Could Accelerate
Supplement Start-Up Revo Biolabs Has Holistic Health, Global Growth In Mind
Sanofi-Aventis Nurtures Supplement Interest With Symbion Consumer Buy
Leiner Plans Suit Against Dr. Reddy’s, Expects Delay Restarting OTC Business
Natrol Pumps Up In Sports Nutrition Market With MRI Acquisition
Experts, FDAer Address Issues Set Ablaze By Melamine Contamination
Experts, FDAer Address Issues Set Ablaze By Melamine Contamination

Topics

Advertisement
UsernamePublicRestriction

Register

PS101142

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel